Zentalis Pharmaceuticals shares owned by Tower Research Capital
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.0k | 64 | 15.77 |
| 2023-09-30 | $21k | 1.0k | 20.04 |
| 2023-06-30 | $195k | 6.9k | 28.21 |
| 2023-03-31 | $36k | 2.1k | 17.22 |
| 2022-12-31 | $0 | 2.6k | 0.00 |
| 2022-09-30 | $130k | 6.0k | 21.59 |
| 2022-06-30 | $215k | 7.6k | 28.14 |
| 2022-03-31 | $24k | 518 | 46.33 |
| 2021-12-31 | $315k | 3.9k | 80.00 |
| 2021-09-30 | $177k | 2.6k | 67.67 |
| 2021-06-30 | $163k | 3.1k | 52.86 |
| 2021-03-31 | $63k | 1.4k | 43.63 |
| 2020-12-31 | $37k | 718 | 51.53 |
| 2020-09-30 | $243k | 9.2k | 26.32 |
| 2020-06-30 | $24k | 510 | 47.06 |
More positions owned by Tower Research Capital
Home Depot (HD)
View all positions for Tower Research Capital